PT Diagnos Laboratorium Utama Tbk (ISX:DGNS) Other Financing: Rp0.00 Mil (TTM As of . 20)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ISX:DGNS PT Diagnos Laboratorium Utama Tbk ISX:DGNS
21 GF Score
Price Rp246.00
! 1 Warning Sign
View Full Analysis

What is PT Diagnos Laboratorium Utama Tbk Other Financing?

PT Diagnos Laboratorium Utama Tbk ISX:DGNS +4.24% 21 Other Financing is Rp0.00 Mil as of . 20. GuruFocus rates ISX:DGNS with a GF Score™ of 21/100. The stock has 1 warning sign investors should review.

PT Diagnos Laboratorium Utama Tbk's Other Financing for the six months ended in . 20 was Rp0.00 Mil.

PT Diagnos Laboratorium Utama Tbk's Other Financing for the trailing twelve months (TTM) ended in . 20 was Rp0.00 Mil.

PT Diagnos Laboratorium Utama Tbk Other Financing Historical Data

* Premium members only.

The historical data trend for PT Diagnos Laboratorium Utama Tbk's Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PT Diagnos Laboratorium Utama Tbk Other Financing Chart

PT Diagnos Laboratorium Utama Tbk Annual Data
Trend
Other Financing

PT Diagnos Laboratorium Utama Tbk Semi-Annual Data
Other Financing
ISX:DGNS
21GF Score
PT Diagnos Laboratorium Utama Tbk ISX:DGNS
Other Financing is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PT Diagnos Laboratorium Utama Tbk Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Other Financing for the trailing twelve months (TTM) ended in . 20 was Rp0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Other Financing →
What does a Other Financing of Rp0.00 Mil mean?
PT Diagnos Laboratorium Utama Tbk (ISX:DGNS) has a Other Financing of Rp0.00 Mil as of . 20. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for PT Diagnos Laboratorium Utama Tbk and its competitors.
Is PT Diagnos Laboratorium Utama Tbk's Other Financing too high?
PT Diagnos Laboratorium Utama Tbk's current Other Financing is Rp0.00 Mil. Overall, PT Diagnos Laboratorium Utama Tbk has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does PT Diagnos Laboratorium Utama Tbk's Other Financing compare to TMO and DHR?
PT Diagnos Laboratorium Utama Tbk's Other Financing of Rp0.00 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Financing for a Medical Diagnostics & Research company?
A good Other Financing depends on the Medical Diagnostics & Research industry context. However, Other Financing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Financing mean?
A high Other Financing can signal that a stock is expensive relative to its fundamentals. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for PT Diagnos Laboratorium Utama Tbk and its competitors. PT Diagnos Laboratorium Utama Tbk's current Other Financing is Rp0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Diagnos Laboratorium Utama Tbk stock overvalued right now?
PT Diagnos Laboratorium Utama Tbk (ISX:DGNS) has a current Other Financing of Rp0.00 Mil. The current Other Financing is Rp0.00 Mil. PT Diagnos Laboratorium Utama Tbk's overall GF Score™ is 21/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Financing calculated?
Other Financing is calculated from a company's financial statements. For PT Diagnos Laboratorium Utama Tbk (ISX:DGNS), the current Other Financing is Rp0.00 Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

PT Diagnos Laboratorium Utama Tbk Business Description

Address Jl. Cikditiro No. 11 A, B, C, Gedung Graha Anam Lantai 2, Kelurahan Gondangdia, Kecamatan Menteng, Jakarta Pusat, Jakarta, IDN, 10350
PT Diagnos Laboratorium Utama Tbk operates in the field of Health Support Services and Private Clinic Activities. It provides health support service activities managed by both the government and the private sector, such as health laboratories in the form of X-Ray Laboratories, and other diagnostic imaging centers, as well as blood testing, private clinics, pharmaceutical warehouses, eye banks, blood banks, sperm banks, organ transplant banks, and other medical support services. Its products and services include Clinical Pathology Laboratory, Anatomical Pathology Laboratory, Genomics Laboratory, Homecare Health Services, Corporate Health Services, Microbiology Laboratory, and Research Services.
21GF Score

Get the complete analysis for ISX:DGNS

Other Financing is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

Rp246.00
Price